Transcription Factor Mutations and Congenital Hypothyroidism: Systematic Genetic Screening of a Population-Based Cohort of Japanese Patients

• Published in: The journal of clinical endocrinology and metabolism Vol. 95; no. 4; pp. 1981 - 1985
• Main Authors: Narumi, Satoshi, Muroya, Koji, Asakura, Yumi, Adachi, Masanori, Hasegawa, Tomonobu
• Format: Journal Article
• Language: English
• Published: United States Endocrine Society 01.04.2010
• Subjects: Cohort Studies; Congenital Hypothyroidism - genetics; Congenital Hypothyroidism - physiopathology; DNA - genetics; Gene Deletion; Gene Duplication; Genetic Testing; HeLa Cells; Humans; Japan; Nucleic Acid Amplification Techniques; Phenotype; Population; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors - genetics; Japan
• ISSN: 0021-972X; 1945-7197
• DOI: 10.1210/jc.2009-2373

Context: Gene mutations of transcription factors that are predominantly expressed in the thyroid gland cause congenital hypothyroidism (CH). The prevalence of CH due to transcription factor mutations remains undetermined. Objective: This study was designed to define the prevalence of CH due to mutations of PAX8, NKX2-1 [encoding thyroid transcription factor (TTF)-1], FOXE1 (encoding TTF-2), and NKX2-5 among patients with permanent primary CH and in the general population in Japan. Subjects and Methods: We enrolled 102 CH patients that represent 353,000 newborns born in Kanagawa prefecture from October 1979 to June 2006. We sequenced PAX8, NKX2-1, FOXE1, and NKX2-5 using PCR-based methods. Additionally, deletion/duplication of PAX8, NKX2-1, and FOXE1 was screened by multiplex ligation-dependent probe amplification. Molecular functions of putative mutations were verified in vitro. Results: We identified a novel small duplication of PAX8 (p.K80_A84dup) in two half-sibling patients with thyroid hypoplasia. We also found a novel NKX2-1 variation (p.H60W) in a sporadic nonsyndromic CH patient. In vitro experiments showed that K80_A84dup PAX8 had impaired transactivation of the thyroglobulin promoter. H60W TTF-1 exhibited a comparable transactivating capacity with wild-type TTF-1, suggesting a benign variation. We estimate the prevalence of PAX8 mutations to be 2.0% (two in 102) among Japanese CH patients and one in 176,000 (two in 353,000) in the general Japanese population. Conclusions: Using a population-based sample, we confirmed that a minor subset of CH patients has transcription factor mutations, but they are rare. In our cohort, PAX8 mutations were the leading cause of such a rare condition. PAX8 mutation is the most common transcription factor mutation associated with congenital hypothyroidism (CH), and accounts for about 2% of CH cases.